• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿波肉毒杆菌毒素A对雷诺现象症状的影响:病例系列

The Effect of Abobotulinum Toxin A on the Symptoms of Raynaud's Phenomenon: A Case Series.

作者信息

Winter Amelia R, Camargo Macias Kathlyn, Kim Sun, Sami Naveed, Weinstein David

机构信息

Internal Medicine, University of Central Florida College of Medicine, Orlando, USA.

Dermatology, University of Central Florida College of Medicine, Orlando, USA.

出版信息

Cureus. 2020 May 22;12(5):e8235. doi: 10.7759/cureus.8235.

DOI:10.7759/cureus.8235
PMID:32582494
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7306670/
Abstract

Raynaud's phenomenon (RP) is a relatively common syndrome occurring alone or in combination with autoimmune and inflammatory diseases. It is characterized by pain and ulceration due to vasospasm in response to cold and stress, most often affecting the digits. Although pharmacologic treatment for this condition exists, it is not always efficacious. Our case series demonstrates the use of abobotulinum toxin A in the treatment of RP. We report the cases of four patients who received injections of abobotulinum toxin A to treat their mild to severe RP symptoms. They experienced clinical improvement for up to one year after treatment.

摘要

雷诺现象(RP)是一种相对常见的综合征,可单独出现或与自身免疫性疾病和炎症性疾病合并出现。其特征是因寒冷和压力引发血管痉挛导致疼痛和溃疡,最常影响手指。尽管针对这种病症有药物治疗方法,但并非总是有效。我们的病例系列展示了阿柏西普肉毒毒素A在治疗RP中的应用。我们报告了4例接受阿柏西普肉毒毒素A注射以治疗其轻至重度RP症状的患者病例。他们在治疗后临床改善持续了长达一年的时间。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ed8/7306670/b04bf2de6354/cureus-0012-00000008235-i11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ed8/7306670/721e6f98fcd6/cureus-0012-00000008235-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ed8/7306670/02c9e9991d84/cureus-0012-00000008235-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ed8/7306670/fb7d7e0cdca4/cureus-0012-00000008235-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ed8/7306670/68c997c67619/cureus-0012-00000008235-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ed8/7306670/369b71c61ce9/cureus-0012-00000008235-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ed8/7306670/61f98e9ab8c6/cureus-0012-00000008235-i06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ed8/7306670/c2943f9203d4/cureus-0012-00000008235-i07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ed8/7306670/2ccffd31d254/cureus-0012-00000008235-i08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ed8/7306670/84b5e2b4a132/cureus-0012-00000008235-i09.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ed8/7306670/a4c146572892/cureus-0012-00000008235-i10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ed8/7306670/b04bf2de6354/cureus-0012-00000008235-i11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ed8/7306670/721e6f98fcd6/cureus-0012-00000008235-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ed8/7306670/02c9e9991d84/cureus-0012-00000008235-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ed8/7306670/fb7d7e0cdca4/cureus-0012-00000008235-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ed8/7306670/68c997c67619/cureus-0012-00000008235-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ed8/7306670/369b71c61ce9/cureus-0012-00000008235-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ed8/7306670/61f98e9ab8c6/cureus-0012-00000008235-i06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ed8/7306670/c2943f9203d4/cureus-0012-00000008235-i07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ed8/7306670/2ccffd31d254/cureus-0012-00000008235-i08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ed8/7306670/84b5e2b4a132/cureus-0012-00000008235-i09.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ed8/7306670/a4c146572892/cureus-0012-00000008235-i10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ed8/7306670/b04bf2de6354/cureus-0012-00000008235-i11.jpg

相似文献

1
The Effect of Abobotulinum Toxin A on the Symptoms of Raynaud's Phenomenon: A Case Series.阿波肉毒杆菌毒素A对雷诺现象症状的影响:病例系列
Cureus. 2020 May 22;12(5):e8235. doi: 10.7759/cureus.8235.
2
Optimisation of botulinum toxin type a treatment for the management of Raynaud's phenomenon using a dorsal approach: a prospective case series.采用背侧入路优化 A 型肉毒毒素治疗雷诺现象:一项前瞻性病例系列研究。
Clin Rheumatol. 2019 Dec;38(12):3669-3676. doi: 10.1007/s10067-019-04762-4. Epub 2019 Sep 3.
3
Clinical and image improvement of Raynaud's phenomenon after botulinum toxin type A treatment.A型肉毒杆菌毒素治疗后雷诺现象的临床及影像学改善
Australas J Dermatol. 2015 Aug;56(3):202-5. doi: 10.1111/ajd.12326. Epub 2015 Mar 29.
4
The Use of Botulinum Toxin in Raynaud Phenomenon: A Comprehensive Literature Review.肉毒杆菌毒素在雷诺现象中的应用:全面文献综述。
Ann Plast Surg. 2023 Jul 1;91(1):159-186. doi: 10.1097/SAP.0000000000003603.
5
Botulinum toxin A treatment of Raynaud's phenomenon: a review.肉毒杆菌毒素 A 治疗雷诺现象:综述。
Semin Arthritis Rheum. 2012 Feb;41(4):599-603. doi: 10.1016/j.semarthrit.2011.07.006. Epub 2011 Aug 24.
6
Raynaud's phenomenon of the nipple: a treatable cause of painful breastfeeding.乳头雷诺现象:母乳喂养疼痛的一个可治疗病因。
Pediatrics. 2004 Apr;113(4):e360-4. doi: 10.1542/peds.113.4.e360.
7
[Botulinum toxin type A contribution in the treatment of Raynaud's phenomenon due to systemic sclerosis].[A型肉毒杆菌毒素在治疗系统性硬化症所致雷诺现象中的作用]
Ann Chir Plast Esthet. 2013 Dec;58(6):658-62. doi: 10.1016/j.anplas.2011.11.001. Epub 2011 Dec 26.
8
Is axillary botulinum toxin efficient in controlling secondary Raynaud's phenomenon? A case report.腋窝注射肉毒杆菌毒素对控制继发性雷诺现象是否有效?一例病例报告。
J Scleroderma Relat Disord. 2021 Oct;6(3):327-329. doi: 10.1177/23971983211034077. Epub 2021 Jul 29.
9
Use of Botulinum Toxin A to Treat Chemotherapy-Induced Raynaud's Phenomenon.使用A型肉毒杆菌毒素治疗化疗引起的雷诺现象。
Cureus. 2021 Jan 5;13(1):e12511. doi: 10.7759/cureus.12511.
10
Botulinum Toxin Type A in the Treatment of Raynaud's Syndrome: A Case Report.A型肉毒杆菌毒素治疗雷诺综合征:一例报告
Cureus. 2024 Mar 31;16(3):e57327. doi: 10.7759/cureus.57327. eCollection 2024 Mar.

引用本文的文献

1
A systematic review of botulinum toxin as a treatment for Raynaud's disease secondary to scleroderma.肉毒杆菌毒素治疗硬皮病继发雷诺病的系统评价。
Clin Rheumatol. 2025 Jan;44(1):81-96. doi: 10.1007/s10067-024-07237-3. Epub 2024 Nov 30.
2
Botulinum Toxin for the Treatment of Raynaud's Conditions of the Hand: Clinical Practice Updates and Future Directions.肉毒毒素治疗手部雷诺现象:临床实践更新及未来方向。
Toxins (Basel). 2024 Nov 1;16(11):472. doi: 10.3390/toxins16110472.
3
Toxin for Treating Raynaud Conditions in Hands (The TORCH Study): A Systematic Review and Meta-analysis.

本文引用的文献

1
Botulinum toxin type A in the treatment of Raynaud's phenomenon: A three-year follow-up study.A型肉毒杆菌毒素治疗雷诺现象:一项为期三年的随访研究。
Eur J Rheumatol. 2018 Dec;5(4):224-229. doi: 10.5152/eurjrheum.2018.18013. Epub 2018 Oct 12.
2
Successful treatment of Raynaud's phenomenon and digital ulcers in systemic sclerosis patients with botulinum toxin B injection: Assessment of peripheral vascular disorder by angiography and dermoscopic image of nail fold capillary.肉毒杆菌毒素 B 注射治疗系统性硬化症患者雷诺现象和指端溃疡的疗效:血管造影和甲襞毛细血管的皮肤镜图像评估外周血管障碍。
J Dermatol. 2018 Mar;45(3):349-352. doi: 10.1111/1346-8138.14140. Epub 2017 Nov 22.
3
用于治疗手部雷诺氏病的毒素(TORCH研究):系统评价与荟萃分析
Plast Reconstr Surg Glob Open. 2024 Jun 14;12(6):e5885. doi: 10.1097/GOX.0000000000005885. eCollection 2024 Jun.
4
Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review.肉毒毒素在皮肤科的治疗用途:系统评价。
Toxins (Basel). 2021 Feb 5;13(2):120. doi: 10.3390/toxins13020120.
The Therapeutic Efficacy of Botulinum Toxin in Treating Scleroderma-Associated Raynaud's Phenomenon: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
肉毒毒素治疗硬皮病相关雷诺现象的疗效:一项随机、双盲、安慰剂对照临床试验。
Arthritis Rheumatol. 2017 Aug;69(8):1661-1669. doi: 10.1002/art.40123. Epub 2017 Jun 26.
4
Efficacy of Botulinum Toxin B Injection for Raynaud's Phenomenon and Digital Ulcers in Patients with Systemic Sclerosis.注射肉毒杆菌毒素B治疗系统性硬化症患者雷诺现象和指端溃疡的疗效
Acta Derm Venereol. 2017 Jul 6;97(7):843-850. doi: 10.2340/00015555-2665.
5
A case report of the beneficial effects of botulinum toxin type A on Raynaud phenomenon in a patient with lung cancer.A型肉毒杆菌毒素对一名肺癌患者雷诺现象有益影响的病例报告。
Medicine (Baltimore). 2016 Oct;95(40):e5092. doi: 10.1097/MD.0000000000005092.
6
Botulinum toxin A in the treatment of Raynaud's phenomenon: a systematic review.A型肉毒杆菌毒素治疗雷诺现象:一项系统评价
Arch Med Sci. 2016 Aug 1;12(4):864-70. doi: 10.5114/aoms.2015.48152. Epub 2015 Jan 8.
7
Conversion Ratio between Botox®, Dysport®, and Xeomin® in Clinical Practice.临床实践中保妥适、吉适和乐提葆之间的换算比例。
Toxins (Basel). 2016 Mar 4;8(3):65. doi: 10.3390/toxins8030065.
8
The Role of Botulinum Toxin A in the Treatment of Raynaud Phenomenon.A型肉毒杆菌毒素在雷诺现象治疗中的作用
Ann Plast Surg. 2016 Sep;77(3):318-23. doi: 10.1097/SAP.0000000000000715.
9
Beneficial effect of botulinum toxin A on Raynaud's phenomenon in Japanese patients with systemic sclerosis: A prospective, case series study.A型肉毒杆菌毒素对日本系统性硬化症患者雷诺现象的有益作用:一项前瞻性病例系列研究。
J Dermatol. 2016 Jan;43(1):56-62. doi: 10.1111/1346-8138.13030. Epub 2015 Jul 15.
10
The role of botulinum toxin in vasospastic disorders of the hand.肉毒杆菌毒素在手部血管痉挛性疾病中的作用。
Hand Clin. 2015 Feb;31(1):23-37. doi: 10.1016/j.hcl.2014.09.003. Epub 2014 Nov 25.